Advertisement
Screener

Verastem, Inc. (VSTM) ROI

Verastem, Inc. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Verastem, Inc. roi for the quarter ending 2018-09-30 was -58.22%.
  • Verastem, Inc. roi for the quarter ending 2018-06-30 was -52.74%.
Available history
2018-06-30 to 2018-09-30
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2018-09-30-58.22%-$79.32M-$21.67M$136.24M
2018-06-30-52.74%-$80.78M-$18.37M$153.15M

Annual ROI

DateROINet income 12 monthDebt plus equity

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Faeth Therapeutics, Inc. (FTH)United States$0.750B
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Wave Life Sciences, Inc. (WVE)$0.780B-5.56